Kipka, H.; Tomasi, R.; Hübner, M.; Liebchen, U.; Hagl, C.; Wanner, K.T.; Mannell, H.; Höfner, G.
Simultaneous LC-ESI-MS/MS Quantification of Levosimendan and Its Metabolites for Therapeutic Drug Monitoring of Cardiac Surgery Patients. Pharmaceutics 2022, 14, 1454.
https://doi.org/10.3390/pharmaceutics14071454
AMA Style
Kipka H, Tomasi R, Hübner M, Liebchen U, Hagl C, Wanner KT, Mannell H, Höfner G.
Simultaneous LC-ESI-MS/MS Quantification of Levosimendan and Its Metabolites for Therapeutic Drug Monitoring of Cardiac Surgery Patients. Pharmaceutics. 2022; 14(7):1454.
https://doi.org/10.3390/pharmaceutics14071454
Chicago/Turabian Style
Kipka, Hannah, Roland Tomasi, Max Hübner, Uwe Liebchen, Christian Hagl, Klaus T. Wanner, Hanna Mannell, and Georg Höfner.
2022. "Simultaneous LC-ESI-MS/MS Quantification of Levosimendan and Its Metabolites for Therapeutic Drug Monitoring of Cardiac Surgery Patients" Pharmaceutics 14, no. 7: 1454.
https://doi.org/10.3390/pharmaceutics14071454
APA Style
Kipka, H., Tomasi, R., Hübner, M., Liebchen, U., Hagl, C., Wanner, K. T., Mannell, H., & Höfner, G.
(2022). Simultaneous LC-ESI-MS/MS Quantification of Levosimendan and Its Metabolites for Therapeutic Drug Monitoring of Cardiac Surgery Patients. Pharmaceutics, 14(7), 1454.
https://doi.org/10.3390/pharmaceutics14071454